137 related articles for article (PubMed ID: 4128113)
1. Carcinoembryonic antigens of erythrocyte membranes.
Nery R; Bullman H; Barsoum AL
Nat New Biol; 1973 Nov; 246(150):44-6. PubMed ID: 4128113
[No Abstract] [Full Text] [Related]
2. Epithelial markers in prostatic, bladder, and colorectal cancer: an immunoperoxidase study of epithelial membrane antigen, carcinoembryonic antigen, and prostatic acid phosphatase.
Heyderman E; Brown BM; Richardson TC
J Clin Pathol; 1984 Dec; 37(12):1363-9. PubMed ID: 6392348
[TBL] [Abstract][Full Text] [Related]
3. [Carcinoembryonic antigen in oncology].
Tkacheva GA
Med Radiol (Mosk); 1983 Aug; 28(8):69-76. PubMed ID: 6310310
[No Abstract] [Full Text] [Related]
4. Aspects of the structure and clinical role of the carcinoembryonic antigen (CEA) and related macromolecules with particular reference to urothelial carcinoma.
Neville AM; Nery R; Hall RR; Turberville C; Laurence DJ
Br J Cancer Suppl; 1973 Aug; 1():198-207. PubMed ID: 4216361
[No Abstract] [Full Text] [Related]
5. Immunochemical studies of the intramolecular heterogeneity of the carcinoembryonic antigen (CEA) of the human digestive system.
Gold JM; Banjo C; Freedman SO; Gold P
J Immunol; 1973 Dec; 111(6):1872-9. PubMed ID: 4127301
[No Abstract] [Full Text] [Related]
6. Isolation and partial characterization of macromolecular urinary aggregates containing carcinoembryonic antigen-like activity.
Nery R; James R; Barsoum AL; Bullman H
Br J Cancer; 1974 Jun; 29(6):413-24. PubMed ID: 4136840
[TBL] [Abstract][Full Text] [Related]
7. Clinical value of tumour-associated antigens.
Neville AM
J Clin Pathol Suppl (R Coll Pathol); 1974; 7():119-26. PubMed ID: 4208587
[No Abstract] [Full Text] [Related]
8. [Radioimmunoassay of carcinoembryogenic antigen (CEA) in patients with carcinoma. Conclusion from preliminary results of a collaborative study in Switzerland].
Mach JP; Pusztaszeri G; Dysli M; Kapp F; Bierens de Haan B; Loosli RM; Grob P; Isliker H
Schweiz Med Wochenschr; 1973 Mar; 103(10):365-71. PubMed ID: 4120789
[No Abstract] [Full Text] [Related]
9. Carcinoembryonic antigen-like substances of human urothelial carcinomas. Isolation of components from pathological urine and comparison with colorectal carcinoma antigens.
Nery R; Barsoum AL; Bullman H; Neville AM
Biochem J; 1974 May; 139(2):431-40. PubMed ID: 4475593
[TBL] [Abstract][Full Text] [Related]
10. Tumor markers in bladder cancer.
Huben RP
Urology; 1984 Mar; 23(3 Suppl):10-4. PubMed ID: 6367189
[No Abstract] [Full Text] [Related]
11. Carcinoembryonic antigen (CEA) in feces and plasma of normal subjects and patients with colorectal carcinoma.
Elias EG; Holyoke ED; Chu TM
Dis Colon Rectum; 1974; 17(1):38-41. PubMed ID: 4204181
[No Abstract] [Full Text] [Related]
12. Factors which influence the radioimmunoassay of carcinoembryonic antigen (CEA).
Hughes NR
Mol Immunol; 1980 May; 17(5):665-73. PubMed ID: 6783829
[No Abstract] [Full Text] [Related]
13. Immunologic studies of glycoproteins isolated from cell membranes of human lung carcinomas.
Tillack TW; Rosai J; Vervynck DJ
J Natl Cancer Inst; 1974 Apr; 52(4):1059-67. PubMed ID: 4133198
[No Abstract] [Full Text] [Related]
14. Value of carcinoembryonic antigen in clinical medicine.
Beatty JD; Terz JJ
Prog Clin Cancer; 1982; 8():9-29. PubMed ID: 6760251
[No Abstract] [Full Text] [Related]
15. A clinical evaluation of the triple-isotope double-antibody radioimmunoassay for carcinoembryonic antigen.
Fritsche HA; Tashima CK; Romsdahl MM; Holoye PY; Geitner A
Am J Clin Pathol; 1978 Feb; 69(2):140-6. PubMed ID: 629223
[No Abstract] [Full Text] [Related]
16. The clinical utility of plasma and urinary carcinoembryonic antigen in patients with genitourinary disease.
Fleisher M; Grabstald H; Whitmore WF; Pinsky CM; Oettgen HF; Schwartz MK
J Urol; 1977 May; 117(5):635-7. PubMed ID: 558345
[TBL] [Abstract][Full Text] [Related]
17. Demonstration of carcinoembryonic antigens (CEA), nonspecific cross-reacting antigens (NCA) and an associated alpha protein in normal human tissues and fluids by immunodiffusion techniques.
Orjasaeter H
Acta Pathol Microbiol Scand B Microbiol Immunol; 1974 Jun; 82(3):387-95. PubMed ID: 4136624
[No Abstract] [Full Text] [Related]
18. ABO (H) blood group antigens and carcinoembryonic antigens as indicators of malignant potential in patients with transitional cell carcinoma of the bladder.
Nakatsu H; Kobayashi I; Onishi Y; Igawa M; Ito H; Tahara E; Nihira H
J Urol; 1984 Feb; 131(2):252-7. PubMed ID: 6366250
[TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical evaluation of nonspecific cross reactive antigen and carcinoembryonic antigen (CEA) in urinary bladder carcinoma.
Asamoto M; Fukushima S; Tatemoto Y; Yamada K; Yuba R; Mori M
Anticancer Res; 1989; 9(2):319-26. PubMed ID: 2751258
[TBL] [Abstract][Full Text] [Related]
20. Measurement of a monoclonal-antibody-defined antigen (CA19-9) in the sera of patients with malignant and nonmalignant diseases. Comparison with carcinoembryonic antigen.
Gupta MK; Arciaga R; Bocci L; Tubbs R; Bukowski R; Deodhar SD
Cancer; 1985 Jul; 56(2):277-83. PubMed ID: 2408729
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
